Drug Alerts - 2024 | Department of Health

Drug alerts issued by DoH during 2024

Documents

PHC-14-2024 Ltd, Suprefact 1 mg ml solution for injection (Cheplapharm Canadian Livery) PL N A
PDF (69 KB)

PHC-13-2024 - Internazionale Srl, Invokana 300mg tablets (Northern Ireland only) PL EU 1 13 884 006
PDF (28 KB)

PHC 12 2024 - Codamol 8 500mg Effervescent Tablets, (Key Pharmaceuticals Livery) PL 0142 1258
PDF (29 KB)

HE1 24 149868 - Myers Squibb Pharmaceuticals Limited OPDIVO 10 mg mL concentrate for solution for infusion (nivolumab) PLGB 15105 0133
PDF (29 KB)

PHC-10-2024 - Class 4 Notification - Fresenius Kabi Limited - Sodium Chloride ~ PL 08828 0084
PDF (96 KB)

PHC-09-2024 - Class 2 recall - Sodiofolin - Tuesday 12 March - MDR 080-03 24 - Final
PDF (29 KB)

PHC-08-2024 - Class 3 Medicines Recall - Besins Healthcare (UK) ~ Pack 750 micrograms actuation Gel
PDF (30 KB)

PHC-07-2024 - Class 4 Medicines Notification - Orifarm UK ~ Concerta XL prolonged release tablets
PDF (53 KB)

PHC-06-2024 - Class 2 Medicines Recall - Novartis ~ Adakveo 10 mg ml concentrate for solution for infusion PLGB 00101 1191(2)
PDF (53 KB)

PHC-05-2024 - Class 3 Medicines Recall - Torrent Pharma (UK) Limited, Ramipril 1.25mg tablets, PL 36687 0222
PDF (97 KB)

PHC-04-2024 - Class 4 Medicines Notification - Exeltis UK Limited, Gepretix 100mg Capsules PL 44081 0009
PDF (104 KB)

PHC-03-2024 - Class 4 Medicines Notification - Cadila Pharmaceuticals (UK) Limited - Pantoprazole 40 mg PL 45841 0018(2)
PDF (31 KB)

PHC-02-2024 - Class 4 Medicines Notification - USV UK Limited, Sugammadex 100 mg ml - PL 32870 0059
PDF (30 KB)

PHC-01-2024 - Class 4 Medicines Notification - Quadrant Pharmaceuticals Ltd, Cozaar 100mg film-coated tablets, PLPI 20774 1830
PDF (30 KB)

Help viewing documents